Toga Pulla embroidered platform espadrilles sale newest cheap Manchester top quality cheap price discount 2014 vvgR9T3MF

SKU-0010421659
Toga Pulla embroidered platform espadrilles sale newest cheap Manchester top quality cheap price discount 2014 vvgR9T3MF
Toga Pulla embroidered platform espadrilles
ASOS DESIGN Slip On Plimsolls In Black Mesh With Dragon Embroidery discount low shipping PPsetKuD
X Close Message Box

It seems you're using a browser version we no longer support. To get the best online experience, please consider upgrading to one of the following newer browsers.

free shipping new arrival outlet with mastercard M4D3 Richmond Platform Sandals new arrival sale online free shipping wholesale price aHOkNbZT5
prices cheap price Kiss amp; Tell Light Blue buy online new Nlb0YMN6
Apple Safari Adidas black ultra boost clima sneakers 2015 new cheap price FgAuAQM
End of Message Box
Florida Blue
Georgia Boot Athens Mens 10in Waterproof Wellington Work Boots footlocker finishline cheap price buy cheap find great cheap sale discount visit sale latest y8OIR
New York Transit Bring Music Womens Wedge Sandals discount explore lpN2QKquV
Adidas Adidas Originals Quesence sneakers buy cheap geniue stockist clearance footlocker for nice cheap online professional sale online buy cheap discounts VE91bzHiRN
Easy Street Jem Womens High Heel Ankle Boots for sale cheap price from china free shipping buy clearance in China outlet free shipping authentic vAZpnb
English Fendi monogram opentoe sandals outlet cheap online MGy2LXX

Topline results from the first of three Phase 3 trials in psoriasis clinical development program

Share
| Source: Dermira, Inc.

BRUSSELS, Belgium and MENLO PARK, Calif., Oct. 03, 2016 (GLOBE NEWSWIRE) -- UCB (Euronext:UCB) and Dermira, Inc. (NASDAQ:) today announced topline results from CIMPASI-2, a Phase 3, multi-center, placebo-controlled clinical trial evaluating the efficacy and safety of CIMZIA® (certolizumab pegol) in adult patients with moderate-to-severe chronic plaque psoriasis. In the CIMPASI-2 trial, CIMZIA demonstrated statistically significant improvements for both co-primary endpoints compared to placebo at both treatment doses. The CIMPASI-2 trial results are from the first of three Phase 3 clinical trials to be reported evaluating CIMZIA in this patient population. 1

The co-primary endpoints evaluated in the trial were the percentage of patients who achieved a 75% or greater disease improvement from baseline as measured by the Psoriasis Area and Severity Index (PASI 75) and the percentage of patients achieving at least a two-point improvement on a five-point Physician’s Global Assessment (PGA) scale to a final score representing clear or almost clear skin, each compared with placebo, at week 16. 1

A total of 227 patients with moderate-to-severe chronic plaque psoriasis were randomized to three dosing arms—400 mg every two weeks (n=87), 400 mg at weeks 0, 2, and 4 followed by 200 mg every two weeks (n=91), or placebo every two weeks (n=49). At week 16, the response rate for patients who achieved a PASI 75 was 82.6% for patients receiving the 400 mg dose every two weeks and 81.4% for patients receiving the 200 mg dose every two weeks, compared to 11.6% for patients receiving placebo. The response rate for patients achieving at least a two-point improvement to a final score of clear or almost clear skin on the PGA scale at week 16 was 71.6% for the 400 mg dose-treated patients and 66.8% for the 200 mg dose-treated patients, compared to 2.0% for the patients receiving placebo. CIMZIA demonstrated statistically significant improvements from baseline to week 16 relative to placebo for both co-primary endpoints at both treatment doses. The adverse event profile appears consistent with the adverse event profiles observed with CIMZIA in other indications. 1

“The clinical results from the CIMPASI-2 trial are very encouraging and reinforce our belief that CIMZIA may provide clinically meaningful benefit for moderate-to-severe plaque psoriasis patients,” said Tom Wiggans, chairman and chief executive officer of Dermira. “We look forward to data from the two additional ongoing Phase 3 clinical trials, which are expected by the end of the first quarter of 2017.”

Limited time offer: Use code 'FLYJULY18' for 3 months of FREE hosting!

Limited time offer:
Nike Benassi Just Do It Print Sail/Sail Mineral free shipping 2014 new cheap sale high quality sale 100% guaranteed cheap sale big sale bz1gbF6JLD

Never share passwords or create multiple logins again

•••

Streamline your collaboration process

You know you’ve done it — you’ve totally built a spreadsheet with all your client passwords in one place. Flywheel does away with all that. Collaborate easily and instantly with your team without the clunkiness of sharing and storing (and losing. And recovering) passwords.

Fifty and Fifty spends more time building client projects and zero time managing servers

Bryan Monzon is the vice president of engineering at Fifty and Fifty, a company that works on digital products (small and large) for social good. Since starting on Flywheel, Fifty and Fifty have sped up their project complete time and eliminated workflow headaches along the way.

DOWNLOAD

Ditch the spreadsheet filled with passwords. Never ask a client for a password again. Collaborators on Flywheel log in with their own usernames and passwords. They can view and manage all their sites in one place.

Add teammates and clients as collaborators, and they’ll get full access to manage the site, update files, and manage the database.

•••

It’s okay to fall in love with your Flywheel dashboard. Look how pretty it is, showing all the sites you own right next to the ones where you’re a collaborator. With just one login, you can manage all your sites, upload files via SFTP, and modify databases.

When the project is over, remove access from people who don’t need it anymore, and voilà! No more access.

Create a free account

Wyman Projects uses Flywheel to centralize their workflow

View more stories

Try it yourself. It's free takes less than 60 seconds. SIGN UP

Reimagined SFTP

You know you’ve done it – a spreadsheet with all your client passwords in one place. Flywheel frees you from the need to share and store passwords.

Learn More
•••
•••

Test out changes in a test enviroment and easily push to production.

Sleep soundly at night knowing that all your important files are backed up nightly.

When you're done developing, easily transfer a site to your client for payment.

Powerful Tools

Managed Hosting

We'd love hearing from you. Give us a call and we can chat about your needs.

See for yourself how Flywheel can make your life easier.

© GG.COM 2018 | Moncler Venus Stivale snow boots with mastercard 2OGuHH
18+
v5.31.1 | Served in 0.21s by frontend-03